Research output per year
Research output per year
Personal profile
Research interests
Dr. Fehniger is interested in understanding innate immunity and its relationship to cancer. He focuses on the molecular and cellular biology of one innate immune lymphocyte, the natural killer cell, and developing translational immunotherapy strategies that utilize natural killer cells to fight cancer.
Clinical interests
Lymphoma, cellular therapy and bone marrow transplantation
Available to Mentor:
- PhD/MSTP Students
Fingerprint
Dive into the research topics where Todd Fehniger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma
Fehniger, T. A., Watkins, M. P., Ezenwajiaku, N., Wan, F., Hurd, D. D., Cashen, A. F., Blum, K. A., Goy, A., Fenske, T. S., Wagner-Johnston, N. D., Carson, K., Siegel, M. J., Russler-Germain, D., Schneider, S. E., Mehta-Shah, N., Kahl, B. & Bartlett, N. L., Mar 2024, In: Haematologica. 109, 3, p. 953-957 5 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas
Foley, N., Riedell, P. A., Bartlett, N. L., Cashen, A. F., Kahl, B. S., Fehniger, T. A., Fischer, A., Moreno, C., Liu, J., Carson, K. & Mehta-Shah, N., 2024, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article › peer-review
-
A “Prime and Expand” strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy
Shrestha, N., Dee, M. J., Chaturvedi, P., Leclerc, G. M., Mathyer, M., Dufour, C., Arthur, L., Becker-Hapak, M., Foster, M., McClain, E., Pena, N. V., Kage, K., Zhu, X., George, V., Liu, B., Egan, J., Echeverri, C., Wang, M., You, L. & Kong, L. & 6 others, , Sep 2024, In: Cancer Immunology, Immunotherapy. 73, 9, 179.Research output: Contribution to journal › Article › peer-review
Open Access -
Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
Ghobadi, A., Foley, N. C., Cohen, J., Rettig, M. P., Cashen, A. F., Gehrs, L., Christ, S., Street, E., Wallace, N., Ritchey, J., Mehta-Shah, N., Westervelt, P., Fehniger, T. A., Kahl, B., Bartlett, N. L. & DiPersio, J. F., Feb 13 2024, In: Blood Advances. 8, 3, p. 513-522 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation
Foltz, J. A., Tran, J., Wong, P., Fan, C., Schmidt, E., Fisk, B., Becker-Hapak, M., Russler-Germain, D. A., Johnson, J., Marin, N. D., Cubitt, C. C., Pence, P., Rueve, J., Pureti, S., Hwang, K., Gao, F., Zhou, A. Y., Foster, M., Schappe, T. & Marsala, L. & 9 others, , Jun 28 2024, In: Science immunology. 9, 96, eadk4893.Research output: Contribution to journal › Article › peer-review
5 Scopus citations